SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-091952
Filing Date
2024-08-06
Accepted
2024-08-06 16:53:41
Documents
1
Period of Report
2024-07-29

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2114
  Complete submission text file 0000950170-24-091952.txt   3777
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Issuer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1345 AVENUE OF THE AMERICAS, 42ND FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS, 42ND FLOOR NEW YORK NY 10105 917 940 4446
Cortice Biosciences, Inc. (Reporting) CIK: 0002032216 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39126 | Film No.: 241180200